This technology is a deep-contrast AI-enabled algorithm to predict blood-brain barrier (BBB) openings from T1 MRI sequences using low doses of gadolinium-based contrast agents (GBCA).
This technology is a set of fiducial markers that attach to the surgical head holder during robotic neurosurgery to improve precision of volumetric computed tomography scans.
This technology is a method to attenuate the uptake of serum proteins and advanced glycan-end products by bioprosthetic heart valves in order to prevent structural valve leaflet degeneration.
